BioPharma Pharma Research

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

 July 02, 2021 | News

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract...

 July 01, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

 July 01, 2021 | News

Sanofi to Focus on innovating mRNA vaccines beyond pandemic

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...

 June 30, 2021 | News

Evonik markets new advanced technology for sustainable pharmaceutical production

Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...

 June 30, 2021 | News

Körber to start Immunotech’s digital journey towards intelligent manufacturing

Körber and Immunotech Biopharm will implement Werum PAS-X MES in a greenfield cell & gene site in Beijing. This step is an important milestone to ...

 June 29, 2021 | News

RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study

Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...

 June 29, 2021 | News

B dot Medical to test on a compact proton cancer therapy system

  To Realize Compact and Low-cost Proton Therapy System -   B dot Medical Inc. has confirmed the superconductivity of a superconducting be...

 June 28, 2021 | News

Zuellig Pharma to advance Cyber-intelligence Capabilities

Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture   CYFIRMA, a threat discovery and cyb...

 June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

 June 24, 2021 | News

Fujitsu Japan & UOT Embarks on Joint Research for COVID-19 Therapies

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World's Fastest Supercomputer with Researchers of Research Center for Advanced Science...

 June 22, 2021 | News

Ampio Pharmaceuticals, Inc. to Join the Russell Index's

 Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies...

 June 21, 2021 | News

Manufacturing Strategies for mRNA Vaccines and Therapeutics

In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...

 June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments

Shimadzu ,Rakuten Medical to support cancer treatment by photoimmunotherapy

Therapies developed on the Illuminox platform involve administering a targeting moiety conjugated with one or more dyes, which is illuminated by light at a...

 June 18, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close